Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-24 @ 9:44 PM
NCT ID:
NCT01390532
Eligibility Criteria:
Inclusion Criteria:
Chronic heart failure with LVEF \< 35 %, QRS \> 120 ms, NYHA III/IV, optimal medical therapy for more than one month.
* Patient with stable hemodynamic for more than one month,
* More than 18-year old man or woman,
* Patient having given his free, inform and signed consent,
* Patient place setting by the social security system,
Exclusion Criteria:
* Psychiatric disorder
* Any contra-indication to Technetium,
* Any contra-indication to dobutamin or atropin
* Personal or family history of sudden death
* Previous severe ventricular arrhythmia
* Obstructive cardiomyopathy, severe aortic stenosis,
* Pulmonary hypertension,
* History of renal, lung, hepatic, cardiac transplantation,
* Pregnant or breast-feeding Woman,
* Patient who can not conform to the requirements of the protocol,
* Patient included in another medical study,
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01390532
Study Brief:
Protocol Section:
NCT01390532